tafluprost · Thea Pharma · NDA 202514
Zioptan
Earliest generic entry, as listed
28 May 2029
Blocked by patent: US 10864159, US 9999593.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10864159 | drug product, use U-778 · sets the listed date | 28 May 2029 |
| US 9999593 | drug product · sets the listed date | 28 May 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 202514 · 001 · RLD | solution/drops, ophthalmic | 0.0015% | 28 May 2029 |